Bufexamac
CAS No. 2438-72-4
Bufexamac ( Bufexamac; CP-1044-J-3; CP 1044 J 3; CP1044J3; Droxaryl; Parfenac )
Catalog No. M13704 CAS No. 2438-72-4
Bufexamac is a COX inhibitor for IFN-α release.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 32 | In Stock |
|
100MG | 43 | In Stock |
|
200MG | 57 | In Stock |
|
500MG | 78 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBufexamac
-
NoteResearch use only, not for human use.
-
Brief DescriptionBufexamac is a COX inhibitor for IFN-α release.
-
DescriptionBufexamac is a COX inhibitor for IFN-α release.
-
SynonymsBufexamac; CP-1044-J-3; CP 1044 J 3; CP1044J3; Droxaryl; Parfenac
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorIFN-α
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number2438-72-4
-
Formula Weight223.27
-
Molecular FormulaC12H17NO3
-
Purity>98%(HPLC)
-
SolubilityEthanol: 3 mg/mL (13.43 mM); DMSO: 45 mg/mL (201.54 mM)
-
SMILESO=C(NO)CC1=CC=C(OCCCC)C=C1
-
Chemical Name2-(4-butoxyphenyl)-N-hydroxyacetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Krnke B, et al. Contact Dermatitis. 1997 Apr;36(4):212-5.
molnova catalog
related products
-
(R)-Flurbiprofen
A non-steroidal anti-inflammatory drug (NSAID); primarily indicated as a pre-operative anti-miotic as well as orally for arthritis or dental pain; cyclooxygenase (COX) inhibitor.
-
Famprofazone
Famprofazone (Gewodin, Gewolen) is a non-steroidal anti-inflammatory agent (NSAID) of the pyrazolone series .
-
Sodium salicylate
Sodium salicylate is a metabolite of acetylsalicylic acid, and functions by inhibiting NF-kB and reduces oxidative stress.